Crispr Therapeutics: Is it low enough to buy?

preview_player
Показать описание
Greetings, fellow investors! Welcome back to ShareTreck. I'm Raj, this video explains my view of Crispr Therapeutics (CRSP Stock), its current price and potential price trajectory and whether it is a good idea to buy now. These are my personal opinion and not financial advice.

Well this is my personal opinion, not financial advice.

JOIN THE CHANNEL AS A MEMBER:

Please check out the membership offering and join me in the exciting new chapter for ShareTreck, Thanks for your support so far and looking forward to much more. Use the link below to join or click on the Join button on the bottom left of your screen or copy the link below to your browser address bar and press enter.


The videos in this channel should not be construed as financial advice. Always make sure to do your own due diligence and research.
Please do not trade or invest based on this video. Information provided in this video is not investment advice and is for entertainment purposes only.
In case of coverage of pharma companies, disease and therapy details are derived from news articles and publications by companies or research organizations. I am not a doctor but am only facilitating dissemination of published information.
Рекомендации по теме
Комментарии
Автор

Hi Raj
the market may be up to October in a weak position. Without significant news CRSPR may go down. For me it is not a buy at this time. Long term ok, but short term not so well. 😢
Greetings from Greece
Michael

MichaelM
Автор

Vertex said this morning they've collected cells from more than 20+ Casgevy patients and also cautioned a few patients could possibly refuse the infusion step for idiosyncratic reasons. No specific cases were disclosed so probably just speculation.

georgemathai